In this study, we tested the hypothesis that the antitumor effects observed in bacteria-based therapies could result from an adaptive immune response initiated by sequence similarity between bacterial SAgs and specific HSP sequences known to function as tumor Ags. The gene discussed is HSP90B2P; the disease is neoplasm.